Open Access
Open access publishing allows free distribution of and access to published articles. The author retains copyright of their work with a Creative Commons attribution licence, so all articles are made freely available to the widest audience possible.
The benefits are:
- All articles are free to read, copy, distribute, and use (with attribution)
- Author retains copyright - not the publisher
- Complies with self-archiving mandates
Time for change
Fifteen years ago, the business model for scientific publishers was to charge users to view the articles they published.
This subscription-based model was contrary to the interests of authors, funders and the scientific community as a whole, and prevented full use of emerging digital technologies.
It was also becoming unsustainable; increasing amounts of research were being published, whilst library budgets remained static.
BioMed Central's open access publishing model changed all that.
The BioMed Central way
We introduced article-processing charges (APCs) to cover the cost of the publication process, allowing readers free and immediate access to the research articles.
This move put the author at the heart of the publishing process; publishers had to compete to provide the best service at the best price. By coupling the cost of publication to research budgets, APCs also ensured that the journal publishing system could scale to cope with an ever increasing volume of research.
This innovative approach to scientific publishing continues today, and is at the heart of everything we do.
Dear Prof CERASALE MORTEO, We are pleased to announce that the open access journal Pneumoniahas now been transferred to BioMed Central and has fully launched! Please find a selection of recently published articles below, and read our recent guest blog, where Editor-in-Chief Allan Cripps discusses the journal’s history, goals and developments in the field of pneumonia research. Come and meet us at the American Thoracic Society conference in San Francisco on May 13th-18th 2016 and International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD), in Scotland on June 26th-30th 2016. Featured Articles
Journal Scope Pneumonia is the only journal to focus exclusively on pneumonia. Publishing original research, case reports, reviews, commentaries and correspondence, Pneumonia provides an international forum for the exchange of knowledge from the various specialties involved in the pathogenesis, diagnosis, epidemiology, treatment and prevention of pneumonia. Cutting-edge research, insightful reviews and dedication to the community make Pneumonia an essential resource for clinicians, researchers, respirologists and allied professionals involved with infectious diseases. About the Editor-in-Chief  Professor Allan Cripps, Editor-in-Chief, is recognized internationally for his research in the field of mucosal immunology. Much of this work has been directed towards mucosal immunization against a range of bacterial pathogens, particularly those of the respiratory tract. In 2015 he was awarded an Officer of the Order of Australia in recognition of his contributions to mucosal immunization, public health and higher education. Professor Cripps joined Griffith University in May 2003 where he has been responsible for the establishment of the University’s School of Medicine and Health Faculty. He is currently the Executive Head of the Health Faculty at Griffith University. Read more about Professor Cripps on our homepage. Follow Pneumonia on Twitter to keep up to date with the latest research and news on pneumonia. Kind regards, Todd Hummel Editorial Director, BioMed Central For further information or enquiries please contact Customer Services at:info@biomedcentral.com. BioMed Central Ltd 236 Gray's Inn Road, London, WC1X 8HB, United Kingdom. | |||||||||||||||||||||||||||||||||
.png)
No hay comentarios:
Publicar un comentario